BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35578994)

  • 1. Nerve growth factor receptors in equine synovial membranes vary with osteoarthritic disease severity.
    Kendall A; Ekman S; Skiöldebrand E
    J Orthop Res; 2023 Feb; 41(2):316-324. PubMed ID: 35578994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nerve growth factor in the equine joint.
    Kendall A; Nyström S; Ekman S; Hultén LM; Lindahl A; Hansson E; Skiöldebrand E
    Vet J; 2021 Jan; 267():105579. PubMed ID: 33375964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKCδ null mutations in a mouse model of osteoarthritis alter osteoarthritic pain independently of joint pathology by augmenting NGF/TrkA-induced axonal outgrowth.
    Kc R; Li X; Kroin JS; Liu Z; Chen D; Xiao G; Levine B; Li J; Hamilton JL; van Wijnen AJ; Piel M; Shelly DA; Brass D; Kolb E; Im HJ
    Ann Rheum Dis; 2016 Dec; 75(12):2133-2141. PubMed ID: 26783110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic nerve growth factor exposure increases apoptosis in a model of in vitro induced conjunctival myofibroblasts.
    Micera A; Puxeddu I; Balzamino BO; Bonini S; Levi-Schaffer F
    PLoS One; 2012; 7(10):e47316. PubMed ID: 23071784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal p75 and bax overexpression is associated with retinal ganglion cells apoptosis in a rat model of glaucoma.
    Coassin M; Lambiase A; Sposato V; Micera A; Bonini S; Aloe L
    Graefes Arch Clin Exp Ophthalmol; 2008 Dec; 246(12):1743-9. PubMed ID: 18751719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nerve growth factor-induced protein kinase C stimulation contributes to TrkA-dependent inhibition of p75 neurotrophin receptor sphingolipid signaling.
    Plo I; Bono F; Bezombes C; Alam A; Bruno A; Laurent G
    J Neurosci Res; 2004 Aug; 77(4):465-74. PubMed ID: 15264216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Swedish Nerve Growth Factor Mutation (NGF
    Sung K; Ferrari LF; Yang W; Chung C; Zhao X; Gu Y; Lin S; Zhang K; Cui B; Pearn ML; Maloney MT; Mobley WC; Levine JD; Wu C
    J Neurosci; 2018 Apr; 38(14):3394-3413. PubMed ID: 29483280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The p75 neurotrophin receptor enhances TrkA signalling by binding to Shc and augmenting its phosphorylation.
    Epa WR; Markovska K; Barrett GL
    J Neurochem; 2004 Apr; 89(2):344-53. PubMed ID: 15056278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extracellular domain of p75NTR is necessary to inhibit neurotrophin-3 signaling through TrkA.
    Mischel PS; Smith SG; Vining ER; Valletta JS; Mobley WC; Reichardt LF
    J Biol Chem; 2001 Apr; 276(14):11294-301. PubMed ID: 11150291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential activity of the nerve growth factor (NGF) antagonist PD90780 [7-(benzolylamino)-4,9-dihydro-4-methyl-9-oxo-pyrazolo[5,1-b]quinazoline-2-carboxylic acid] suggests altered NGF-p75NTR interactions in the presence of TrkA.
    Colquhoun A; Lawrance GM; Shamovsky IL; Riopelle RJ; Ross GM
    J Pharmacol Exp Ther; 2004 Aug; 310(2):505-11. PubMed ID: 15051797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NGF ligand alters NGF signaling via p75(NTR) and trkA.
    Niederhauser O; Mangold M; Schubenel R; Kusznir EA; Schmidt D; Hertel C
    J Neurosci Res; 2000 Aug; 61(3):263-72. PubMed ID: 10900073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p75 neurotrophin receptor expression on adult human oligodendrocytes: signaling without cell death in response to NGF.
    Ladiwala U; Lachance C; Simoneau SJ; Bhakar A; Barker PA; Antel JP
    J Neurosci; 1998 Feb; 18(4):1297-304. PubMed ID: 9454839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmented pain behavioural responses to intra-articular injection of nerve growth factor in two animal models of osteoarthritis.
    Ashraf S; Mapp PI; Burston J; Bennett AJ; Chapman V; Walsh DA
    Ann Rheum Dis; 2014 Sep; 73(9):1710-8. PubMed ID: 23852764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Pro-Nerve Growth Factor (proNGF) and NGF Binding Protein, α2-Macroglobulin, Differentially Regulates p75 and TrkA Receptors and Is Relevant to Neurodegeneration Ex Vivo and In Vivo.
    Barcelona PF; Saragovi HU
    Mol Cell Biol; 2015 Oct; 35(19):3396-408. PubMed ID: 26217017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TrkA receptor mediates experimental thermal hyperalgesia produced by nerve growth factor: Modulation by the p75 neurotrophin receptor.
    Khodorova A; Nicol GD; Strichartz G
    Neuroscience; 2017 Jan; 340():384-397. PubMed ID: 27826102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synovial nerve fiber density decreases with naturally-occurring osteoarthritis in horses.
    Pujol R; Girard CA; Richard H; Hassanpour I; Binette MP; Beauchamp G; McDougall JJ; Laverty S
    Osteoarthritis Cartilage; 2018 Oct; 26(10):1379-1388. PubMed ID: 29958917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensory Neuron-Specific Deletion of Tropomyosin Receptor Kinase A (
    O-Sullivan I; Kc R; Singh G; Das V; Ma K; Li X; Mwale F; Votta-Velis G; Bruce B; Natarajan Anbazhagan A; van Wijnen AJ; Im HJ
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of nerve growth factor (NGF) and high affinity NGF receptor (p140 TrkA) in human osteoarthritic chondrocytes.
    Iannone F; De Bari C; Dell'Accio F; Covelli M; Patella V; Lo Bianco G; Lapadula G
    Rheumatology (Oxford); 2002 Dec; 41(12):1413-8. PubMed ID: 12468822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of nerve growth factor in neuropathic pain inhibition produced by resiniferatoxin treatment in the dorsal root ganglia.
    Tender GC; Li YY; Cui JG
    Neurosurgery; 2013 Jul; 73(1):158-65; discussion 165-6. PubMed ID: 23615109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid receptors are expressed in equine synovium and upregulated with synovitis.
    Miagkoff L; Girard CA; St-Jean G; Richard H; Beauchamp G; Laverty S
    Equine Vet J; 2023 Jul; 55(4):681-695. PubMed ID: 35836386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.